Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Relapsed or refractory chronic lymphocytic leukemia (CLL) is a type of cancer that affects the white blood cells of the bone marrow. CLL occurs when the white blood cells become cancerous and grow uncontrollably, crowding out healthy cells. This can lead to anemia, fatigue, swollen lymph nodes, and other symptoms.
In many cases, CLL can be successfully treated and even put into remission. However, sometimes the cancer will return or develop resistance to the treatments, making it harder to manage. This is known as relapsed or refractory CLL.
When CLL relapses or is refractory to treatment, it can be difficult to manage. Treatment options will depend on how advanced the cancer is and other prognostic factors. Common treatments for relapsed or refractory CLL include:
- Targeted therapies
- Immunotherapy
- Chemotherapy
- Bone marrow transplant
- Watchful waiting
It is important to work with your doctor to come up with the right treatment plan for your specific case of CLL. The goal of treatment will be to put the cancer into remission for as long as possible, while also helping to manage symptoms. The treatments mentioned above may be used alone or in combination, depending on the situation.
It’s also important to discuss with your doctor any potential side effects of the treatments and any other recommendations. Together you can create a plan to manage your relapsed or refractory CLL in the best way possible.